Dear H.W.: Raloxifene was approved for use in 1997 in the United States as prevention for osteoporosis, and in 2007, it was approved to reduce the risk of breast cancer. Most experts who prescribe ...
More research is needed to address barriers to therapeutic monitoring of prostate cancer patients on androgen deprivation therapy, according to researchers.